Immune-Based Drug Shows Potential Against Another Form of Lung Cancer

Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects

Source: HealthDay
Related MedlinePlus Pages: Lung Cancer, Medicines via MedlinePlus Health News Read More Here..